359 related articles for article (PubMed ID: 30352309)
1. Anti Müllerian Hormone: More than a biomarker of female reproductive function.
Victoria M; Labrosse J; Krief F; Cédrin-Durnerin I; Comtet M; Grynberg M
J Gynecol Obstet Hum Reprod; 2019 Jan; 48(1):19-24. PubMed ID: 30352309
[TBL] [Abstract][Full Text] [Related]
2. The physiology and clinical utility of anti-Mullerian hormone in women.
Dewailly D; Andersen CY; Balen A; Broekmans F; Dilaver N; Fanchin R; Griesinger G; Kelsey TW; La Marca A; Lambalk C; Mason H; Nelson SM; Visser JA; Wallace WH; Anderson RA
Hum Reprod Update; 2014; 20(3):370-85. PubMed ID: 24430863
[TBL] [Abstract][Full Text] [Related]
3. Serum anti-Mullerian hormone assessment of ovarian reserve and polycystic ovary syndrome status over the reproductive lifespan.
Tremellen K; Zander-Fox D
Aust N Z J Obstet Gynaecol; 2015 Aug; 55(4):384-9. PubMed ID: 26230428
[TBL] [Abstract][Full Text] [Related]
4. Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications.
Broer SL; Broekmans FJ; Laven JS; Fauser BC
Hum Reprod Update; 2014; 20(5):688-701. PubMed ID: 24821925
[TBL] [Abstract][Full Text] [Related]
5. Anti-müllerian hormone in the pathophysiology and diagnosis of polycystic ovarian syndrome.
Dumont A; Robin G; Dewailly D
Curr Opin Endocrinol Diabetes Obes; 2018 Dec; 25(6):377-384. PubMed ID: 30299432
[TBL] [Abstract][Full Text] [Related]
6. [Does the serum AMH assay allow predicting reliably female fertility?].
Rolland AL; Dewailly D
Gynecol Obstet Fertil; 2015 Oct; 43(10):670-5. PubMed ID: 26388252
[TBL] [Abstract][Full Text] [Related]
7. Anti-Müllerian hormone as a predictor of reproductive potential.
Hawkins Bressler L; Steiner A
Curr Opin Endocrinol Diabetes Obes; 2018 Dec; 25(6):385-390. PubMed ID: 30299431
[TBL] [Abstract][Full Text] [Related]
8. Role of AMH in Prediction of Menopause.
de Kat AC; Broekmans FJM; Lambalk CB
Front Endocrinol (Lausanne); 2021; 12():733731. PubMed ID: 34594304
[TBL] [Abstract][Full Text] [Related]
9. Use of anti-Müllerian hormone testing during ovarian reserve screening to identify women at risk of polycystic ovary syndrome.
Safier LZ; Grossman LC; Chan CW; Sauer MV; Lobo RA; Douglas NC
Int J Gynaecol Obstet; 2016 Oct; 135(1):73-6. PubMed ID: 27350232
[TBL] [Abstract][Full Text] [Related]
10. Clinical application of serum anti-Müllerian hormone as an ovarian reserve marker: A review of recent studies.
Iwase A; Osuka S; Goto M; Murase T; Nakamura T; Takikawa S; Kikkawa F
J Obstet Gynaecol Res; 2018 Jun; 44(6):998-1006. PubMed ID: 29517134
[TBL] [Abstract][Full Text] [Related]
11. [Anti-Müllerian hormone is a clinical useful measure of the ovarian reserve].
Hyldgaard JM; Ingerslev HJ; Tørring N; Madsen HN; Bor P
Ugeskr Laeger; 2015 Jan; 177(5):V09140477. PubMed ID: 25650516
[TBL] [Abstract][Full Text] [Related]
12. Anti-Müllerian hormone as a qualitative marker - or just quantity?
Kotlyar A; Seifer DB
Curr Opin Obstet Gynecol; 2020 Jun; 32(3):219-226. PubMed ID: 32205525
[TBL] [Abstract][Full Text] [Related]
13. [Level of AMH as a predictor of the result of ovarian stimulation].
Vrublovský P
Ceska Gynekol; 2016 Jan; 81(1):23-6. PubMed ID: 26982060
[TBL] [Abstract][Full Text] [Related]
14. [Measurement of serum AMH levels in gynecology: indications and limits].
Streuli I; Cantero-Perez P; Miserez-Zaugg C
Rev Med Suisse; 2013 Oct; 9(403):1954-6, 1958. PubMed ID: 24245018
[TBL] [Abstract][Full Text] [Related]
15. Is there a place for AMH testing in Canada?
Green JA; Graves G
J Obstet Gynaecol Can; 2011 Jun; 33(6):628-632. PubMed ID: 21846454
[TBL] [Abstract][Full Text] [Related]
16. The use of anti-Müllerian hormone for controlled ovarian stimulation in assisted reproductive technology, fertility assessment and -counseling.
Pilsgaard F; Grynnerup AG; Løssl K; Bungum L; Pinborg A
Acta Obstet Gynecol Scand; 2018 Sep; 97(9):1105-1113. PubMed ID: 29476703
[TBL] [Abstract][Full Text] [Related]
17. [Usefulness and indications of AMH assay in women].
Fouquet A; Catteau-Jonard S; Peigné M; Pigny P; Dewailly D
Ann Biol Clin (Paris); 2014; 72(6):681-8. PubMed ID: 25486664
[TBL] [Abstract][Full Text] [Related]
18. AMH as the primary marker for fertility.
Dewailly D; Laven J
Eur J Endocrinol; 2019 Dec; 181(6):D45-D51. PubMed ID: 31398713
[TBL] [Abstract][Full Text] [Related]
19. [Value of anti-Müllerian hormone in predicting pregnant outcomes of polycystic ovary syndrome patients undergone assisted reproductive technology].
Li Y; Tan JQ; Mai ZY; Yang DZ
Zhonghua Fu Chan Ke Za Zhi; 2018 Jan; 53(1):23-30. PubMed ID: 29374882
[No Abstract] [Full Text] [Related]
20. [What's new in 2014 about anti-Müllerian hormone?].
Seroka-Vanhove A; Sonigo C; Roche C; Grynberg M
J Gynecol Obstet Biol Reprod (Paris); 2014 Oct; 43(8):559-71. PubMed ID: 25042625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
